Cervical Cancer Screening Should Begin at Age 25, Regardless of Sexual Activity
Cervical cancer screening should start at age 25 years for all women, including those who are sexually active, regardless of when they initiated sexual intercourse. 1
Key Recommendation
The American Cancer Society updated its guidelines in 2020, moving away from the previous age-21 recommendation to now recommend screening initiation at age 25 years 1. This represents a significant shift from earlier guidelines that tied screening to sexual activity onset.
Why Age 25, Not Earlier?
The rationale for delaying screening until age 25 is based on several critical factors:
- Minimal disease burden: Only 0.8% of all cervical cancer cases occur in women aged 20-24 years, compared to 4% in women aged 25-29 years 1
- Low mortality impact: Only 0.5% of cervical cancer deaths are attributable to diagnosis at ages 20-24 years 1
- High rate of transient HPV infections: Women under 25 have the highest incidence and prevalence of HPV infection, but most infections clear spontaneously without intervention 1
- Treatment harms: Unnecessary treatment of transient lesions in younger women can lead to adverse obstetric outcomes, including preterm birth 1
Sexual Activity Is No Longer a Factor
This is a critical departure from older guidelines. Previously, screening was recommended to begin 3 years after first sexual intercourse or at age 21, whichever came earlier 2, 3. The 2020 ACS guidelines explicitly state that screening should begin at age 25 regardless of age of first vaginal intercourse 1.
Screening Methods at Age 25
When screening begins at age 25, the preferred approach is:
- Primary HPV testing every 5 years (preferred) 1
- Co-testing (HPV + cytology) every 5 years (acceptable) 1
- Cytology alone every 3 years (acceptable during transition period) 1
Common Pitfalls to Avoid
Do not screen women aged 21-24 years, even if sexually active. Research shows that many young women receive unnecessary Pap tests contrary to guidelines—approximately 59% of women aged 15-20 who initiated sex within the previous 3 years reported having a Pap test, despite this being inconsistent with evidence-based recommendations 4. This represents significant overscreening with potential for harm.
Important Exceptions
These recommendations apply to average-risk women only. Different screening protocols apply to:
- Immunosuppressed individuals (including HIV-positive women)
- Women with history of cervical precancer or cancer
- Women with in utero diethylstilbestrol exposure
For these high-risk populations, earlier and more frequent screening may be warranted 1.